SCI
24April
AssessmentofaContralateralEsophagus–SparingTechniqueinLocallyAdvancedLungCancerTreatedWithHigh-DoseChemoradiation
APhase1NonrandomizedClinicalTrial
（IF:JAMAOncol.22.）
KamranSC,YeapBY,UlysseCA,CroninC,BowesCL,DurginB,GainorJF,KhandekarMJ,TanskyJY,KeaneFK,OlsenCC,WillersH.AssessmentofaContralateralEsophagus-SparingTechniqueinLocallyAdvancedLungCancerTreatedWithHigh-DoseChemoradiation:APhase1NonrandomizedClinicalTrial.JAMAOncol.Apr8.
CorrespondingAuthor:HenningWillers,MD,DepartmentofRadiationOncology,MassachusettsGeneralHospital,55FruitSt,Cox3,Boston,MA(hwillers
mgh.harvard.edu).IMPORTANCE重要性
Severeacuteesophagitisoccursinupto20%ofpatientswithlocallyadvancedlungcancertreatedwithchemoradiationtherapytoatleast60Gyoncedailyandrepresentsadose-limitingtoxiceventassociatedwithpoorout